Wire Jailing at Side Branch to Prevent Occlusion After Main Vessel Stenting: Should It Be the Standard of Care?

While the ideal treatment for coronary bifurcation is provisional stenting, this can be associated with side branch occlusion, which leads to severe adverse events. To prevent this complication, several treatments have been proposed. One of them is wire jailing at side branch before stent implantation in the main vessel. However, the actual benefit of this strategy has not yet been evaluated.

Enjaular la cuerda en la rama lateral para prevenir oclusión luego del stent en el vaso principal, ¿debemos hacerlo rutinariamente?

The aim of this study was to evaluate the angiographic and clinical impact of wire jailing prior to main vessel stenting (second-generation stent).

The primary endpoint was side branch occlusion after stent implantation, defined as a Thrombolysis In Myocardial Infarction (TIMI) flow grade <3. The secondary endpoint included 1) treated-lesion failure, defined as cardiovascular death, acute myocardial infarction, and lesion revascularization; 2) treated-lesion failure only, and 3) angiographic and procedural success.

Researchers conducted an analysis of COBIS III (Coronary Bifurcation Stenting), a retrospective, multicenter, observational registry. A total of 1890 patients who met the inclusion criteria were included and divided into two groups: the wire jailing group (N = 819, 43%), and the non-wire jailing group (N = 1071, 56%).

There was no difference between populations. Mean patient age was 63 years old, and around 70% were male. Half the patients were hypertensive and 30% suffered from diabetes mellitus. The wire jailing group had higher rates of true bifurcation lesions and left main coronary artery disease.

Read also: Provisional vs Dual Stenting in Left Main: An Endless Discussion?

The most frequent presentation was acute coronary syndrome.

There were no significant differences in the primary endpoint (wire jailing 1.8% vs. non-wire jailing 2.9%; hazard ratio [HR]: 0.62; 95% confidence interval [CI]: 0.33-1.16; p = 0.133) or the secondary endpoint. Furthermore, there was no difference in angiographic and procedural success, nor in patient follow-up (mean of 52 months).

There were significant differences in side branch occlusion in patients with >60% stenosis in side branch or main vessel (HR: 0.30; 95% CI: 0.12-0.69; p = 0.007), in favor of those with guidewire use on the secondary branch.

Conclusion

In the 1-stent strategy for the treatment of bifurcation lesions with second-generation stents, wire jailing the side branch before main vessel stenting was associated with a decrease in the rate of side branch occlusion in patients with severe lesions in the main vessel or side branch, but there were no differences in all types of bifurcations or in long-term clinical follow-up.

Randomized studies are needed to clarify the role of this technique.

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez.
Member of the Editorial Board, SOLACI.org

Original Title: Effect of Wire Jailing at Side Branch in 1-Stent Strategy for Coronary Bifurcation Lesions

Reference: Yeon-Jik Choi et al. J Am Coll Cardiol Intv. 2022 Feb, 15 (4) 443–455.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Left Main Coronary Artery Disease: Intravascular Imaging-Guided PCI vs. Coronary Artery Bypass Grafting

Multiple randomized clinical trials have demonstrated superior outcomes with coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in patients with left main...

AHA 2025 | OCEAN Study: Anticoagulation vs. Antiplatelet Therapy After Successful Atrial Fibrillation Ablation

After a successful atrial fibrillation (AF) ablation, the need to maintain long-term anticoagulation (AC) remains uncertain, especially considering the very low residual embolic risk...

AHA 2025 | VESALIUS-CV: Evolocumab in High-Cardiovascular-Risk Patients Without Prior MI or Stroke

LDL cholesterol is a well-established factor for cardiovascular disease. Therapy with PCSK9 inhibitors, including evolocumab, has been shown to reduce the risk of cardiovascular...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....